|
 DXY is exactly what Beijing has said it's looking to support after
it pinpointed remote healthcare, Internet and technology as drivers
to solve its healthcare woes in a 5-year roadmap in March.
The reality is rather different: DXY is curbing plans to work with
public hospitals to help connect doctors and patients online because
of a lack of support by Beijing and obstacles working with China's
huge, fragmented public healthcare sector.
"We've heard a lot of good stories from the top - Internet +,
driving force, policy changing - but see nothing happen at the
bottom," Li told Reuters. "It's not about market, capital or even
tech - these things are already developed very well ... rather it's
the regulations, laws and systems of support."
Li's position reflects wider obstacles to healthcare reforms in
technology, online drug sales, hospital privatization and doctors'
pay, drivers that are a major lure for investors and firms betting
billions of dollars on China opening up a market set to be worth
around $1.3 trillion by 2020.
"[Investors] always ask: is there actually a macro tailwind, and is
the government and regulatory environment - which is very important
in China - supportive of this?" said Alexander Ng, associate
principal at McKinsey & Co.
"If there's a lot of negative voices it might make investors back
off or calculate a much higher risk premium."
REFORM RHETORIC
China has ramped up its healthcare reform rhetoric, touting greater
access for foreign investors to healthcare services, a bigger role
for technology and pushing drug sales from mostly state-run
hospitals towards the retail market.
This has helped draw in close to $30 billion worth of healthcare
merger and acquisition investment so far this year, a fivefold leap
from the same period in 2014, according to Reuters data. Healthcare
M&A already leapt last year.
But, despite the government's longer-term ambitions, industry
insiders say reforms are being held up because of technical issues
such as crumbling and fragmented IT systems to in-fighting between
regulators and push-back from the state-run firms who dominate the
sector - and don't want change.
"With so many vested interests - dealers, hospitals, insurance
departments and others - reform is not very fast," said Frank Zhao,
chief financial officer at China Jo Jo Drugstores Inc.
Privately, some health policy advisers admit reforms are falling
behind, while the public line is that reform has "hit up against the
Yangtze River", a reference to the obstacle famously overcome by Mao
Zedong's Communist forces in 1949.
The healthcare ministry did not respond to faxed queries seeking
comment for this article.
Zhao points to the expected approval for online prescription drug
sales, which he and other industry insiders say has been delayed
this year due to regulatory concerns and opposition from state-run
hospitals and distributors.
[to top of second column] |
These hold-ups are a frustration for pharmacy chains like Jo Jo as
it looks to increase its business online, but also for tech giants
like Alibaba Group Holding Ltd, which wants to get into the online
prescription drug space.
OPEN MARKET?
One big draw for investors has been China's privatization drive of
healthcare services - touted as key to revamping an unpopular
healthcare system, blighted by crowded hospitals, corruption and
simmering tension between patients and staff.
But, despite the fast growth of private investment in hospitals, the
public sector still dominates around 90 percent of all patient
visits, according to a Deutsche Bank 2015 healthcare report.
Investors cite issues with insurance schemes, access to Chinese
doctors and a still tightly-controlled market.
"With things still not market-led, organizations like ours are
facing huge challenges and difficulties," Hu Lan, President and
Director of hospital investment firm AMCARE Corporation, said at a
conference in Shanghai in June.
Healthcare spending as a slice of China's GDP also remains small at
around 6 percent in 2013 compared to 17 percent in the United
States, World Health Organization (WHO) data show.
Reforms to reduce hospitals' reliance on drug sales also faces a
revolt from doctors who argue this will take away a key revenue
stream at a time when medical staff are overworked, underpaid and
often violently abused by angry patients.
"Every few days you hear about a doctor being beaten or even killed.
This situation is a huge mental burden for doctors," said Wu Xiaobo
a doctor at the Wangjing Hospital in Beijing in a recent viral video
campaign for doctors' rights.
As for DXY's Li, his firm now plans to change tack and set up an
offline clinic in the eastern city of Hangzhou this year to pilot
potential healthcare reforms - outside the state sector.
"We were hoping we could leverage changing policy and do something
on mobile and digital," Li said. "We found it's just too slow, so
the only way to do it is out on our own."
(Reporting by Adam Jourdan; Editing by Ian Geoghegan)
[© 2015 Thomson Reuters. All rights
reserved.] Copyright 2015 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |
